ACTU
ACTU
NASDAQ · Biotechnology

Actuate Therapeutics Inc

$2.15
-0.12 (-5.29%)
As of Mar 29, 10:42 PM ET ·
Financial Highlights (FY 2025)
Revenue
11.82M
Net Income
3.06M
Gross Margin
58.2%
Profit Margin
25.9%
Rev Growth
+9.7%
D/E Ratio
0.16
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 58.2% 58.2% 58.2%
Operating Margin 25.8% 26.0% 27.0%
Profit Margin 25.9% 21.7% 23.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 11.82M 10.52M 11.40M
Gross Profit 6.88M 6.12M 6.64M
Operating Income 3.05M 2.73M 3.08M
Net Income 3.06M 2.28M 2.66M
Gross Margin 58.2% 58.2% 58.2%
Operating Margin 25.8% 26.0% 27.0%
Profit Margin 25.9% 21.7% 23.3%
Rev Growth +9.7% +22.7% +8.4%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 8.56M 8.50M 10.38M
Total Equity 53.75M 65.18M 64.60M
D/E Ratio 0.16 0.13 0.16
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 4.32M 3.67M 4.36M
Free Cash Flow 3.21M 3.03M 2.01M